The Medical Letter on Drugs and Therapeutics: Difference between revisions
No edit summary |
wording, that was way too spammy; fact tag |
||
| Line 2: | Line 2: | ||
| cover = <!-- Commented out because image was deleted: [[image:tml_on_drugs_w-website.gif|200px|center]] --> |
| cover = <!-- Commented out because image was deleted: [[image:tml_on_drugs_w-website.gif|200px|center]] --> |
||
| discipline = [[Publication]] |
| discipline = [[Publication]] |
||
| language = [[English language|English]], [[French language|French]], [[Italian language|Italian]], [[Japanese language|Japanese]], [[Spanish language|Spanish]] and a |
| language = [[English language|English]], [[French language|French]], [[Italian language|Italian]], [[Japanese language|Japanese]], [[Spanish language|Spanish]] and a Canadian adapted version, written in English |
||
| abbreviation = Med Lett Drugs Ther |
| abbreviation = Med Lett Drugs Ther |
||
| publisher = [[The Medical Letter, Inc.]] |
| publisher = [[The Medical Letter, Inc.]] |
||
| Line 11: | Line 11: | ||
}} |
}} |
||
'''''The Medical Letter on Drugs and Therapeutics''''', commonly referred to as ''The Medical Letter'', |
'''''The Medical Letter on Drugs and Therapeutics''''', commonly referred to as ''The Medical Letter'', is a [[scientific journal]] that promotes itself as providing independent, evaluations of [[drug]]s on the basis of novel information. The Medical Letter is well known as the "Gold Standard", for new drug review within the medical community for over five decades.{{fact}} |
||
The Medical Letter has a print and electronic circulation of well over 450,000 subscribers in 125 countries worldwide. |
The Medical Letter has a print and electronic circulation of well over 450,000 subscribers in 125 countries worldwide. |
||
| Line 17: | Line 17: | ||
Published biweekly (26 issues/year), the newsletter is available in several languages: [[English language|English]] (US and Canadian editions), [[French language|French]] (Canadian and European editions), [[Italian language|Italian]], [[Japanese language|Japanese]], and [[Spanish language|Spanish]].The Medical Letter is also available as an electronic site license for institutions such as medical schools, hospitals and group practices. |
Published biweekly (26 issues/year), the newsletter is available in several languages: [[English language|English]] (US and Canadian editions), [[French language|French]] (Canadian and European editions), [[Italian language|Italian]], [[Japanese language|Japanese]], and [[Spanish language|Spanish]].The Medical Letter is also available as an electronic site license for institutions such as medical schools, hospitals and group practices. |
||
''The Medical Letter'' is published by [[The Medical Letter, Inc.]], which also publishes the monthly ''[[Treatment Guidelines from The Medical Letter]]''. |
''The Medical Letter'' is published by [[The Medical Letter, Inc.]], which also publishes the monthly ''[[Treatment Guidelines from The Medical Letter]]''. |
||
== Editorial Process == |
== Editorial Process == |
||
Revision as of 14:12, 29 June 2010
| Discipline | Publication |
|---|---|
| Language | English, French, Italian, Japanese, Spanish and a Canadian adapted version, written in English |
| Publication details | |
| History | first published 1959 |
| Publisher | |
| Standard abbreviations | |
| ISO 4 | Med Lett Drugs Ther |
| Indexing | |
| ISSN | 1523-2859 |
| Links | |
The Medical Letter on Drugs and Therapeutics, commonly referred to as The Medical Letter, is a scientific journal that promotes itself as providing independent, evaluations of drugs on the basis of novel information. The Medical Letter is well known as the "Gold Standard", for new drug review within the medical community for over five decades.[citation needed]
The Medical Letter has a print and electronic circulation of well over 450,000 subscribers in 125 countries worldwide.
Published biweekly (26 issues/year), the newsletter is available in several languages: English (US and Canadian editions), French (Canadian and European editions), Italian, Japanese, and Spanish.The Medical Letter is also available as an electronic site license for institutions such as medical schools, hospitals and group practices.
The Medical Letter is published by The Medical Letter, Inc., which also publishes the monthly Treatment Guidelines from The Medical Letter.
Editorial Process
An expert consultant or one of the editors prepares the preliminary draft using both published and available unpublished studies that are carefully examined, paying special attention to the results of well controlled clinical trials.
The preliminary draft is edited and sent to every member of the Advisory Board, to 10-20 other investigators who have clinical and experimental experience with the drug or type of drug or disease under review, to the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), to the first authors of all the articles cited in the text, to appropriate agents of the pharmaceutical companies making the drugs under review, and to drug companies that make similar compounds. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents.
Many critical observations, suggestions and questions are received from the reviewers and are incorporated into the article during the revision process, and the article is checked and edited to make sure the final appraisal is not only accurate, but also easy to read.
flowchart of the editorial process
See also
- New England Journal of Medicine
- Journal of the American Medical Association
- The Lancet
- British Medical Journal
- Annals of Internal Medicine
- Archives of Internal Medicine
- List of medical journals